C&EN eBook
Quality innovations in monoclonal antibody manufacturing
Brought to you by Thermo Fisher Scientific

Antibody therapeutics provide cell-specific recognition customized for a patient. They offer the ability to treat cancers and autoimmune diseases with fewer side effects than traditional treatments such as chemotherapy. As the scientific understanding of traditional monoclonal antibody therapeutics has advanced, researchers have moved into engineering proteins to create next-generation antibody modalities.

This e-book explores solutions for common purification, analysis, and quality evaluation challenges when manufacturing modern antibody-derived therapies. Tools such as affinity chromatography, quantitative polymerase chain reaction (qPCR), and single-domain antibodies provide effective and flexible solutions for improving the efficiency and reliability of antibody biomanufacturing practices.

Key Objectives:
  • Affinity purification for monoclonal antibody manufacturing
  • Using quantitative PCR to test for residual DNA from biomanufacturing processes
  • Innovative uses of single-domain antibodies in monoclonal therapeutic research and development

Brought to you by:
Thermo Fisher Scientific
Please complete the form to download the eBook.

*I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com.

I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2023 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy